Seoul, Seoul-t'ukpyolsi, South Korea The typical case for the fund is to invest in rounds with 1 participant. In the next rounds fund is usually obtained by Medici Investment, Ildong Pharmaceutical, Aju Pharma.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2016. The top amount of exits for fund were in 2012. The fund is constantly included in less than 2 investment rounds annually.
We can highlight the next thriving fund investment areas, such as Diabetes, Biotechnology. Among the various public portfolio startups of the fund, we may underline Rezolute Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
| Fund Name | Location |
| Affinity Asset Advisors | New York, New York, United States |
| Air Force Research Laboratory | - |
| Beijing Phoenix Wealth Holding Group | - |
| China Elite Capital | - |
| Fengjin Zichan | China, Shanghai |
| FirePower Capital | Canada, Ontario, Toronto |
| Flerie Invest | - |
| Global Risk Technologies | County Dublin, Dublin, Ireland |
| Highland Creek Partners | Canada, Ontario, Toronto |
| Humanity United | California, San Francisco, United States |
| InnoSpace | China, Hong Kong, Hong Kong Island |
| M. R. Al Khathlan | - |
| Revolution Ventures | District of Columbia, United States, Washington |
| Slant Design + Marketing Inc. | British Columbia, Canada, Vancouver |
| Sonae | Maia, Porto, Portugal |
| Sun Strategies | New York, New York, United States |
| Talwalkars | India, Maharashtra, Mumbai |
| Wafra Inc. | New York, New York, United States |
| Zhongsou Investment | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Pliant Therapeutics | $45M | 18 Feb 2016 | South San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Pliant Therapeutics | $45M | 18 Feb 2016 | South San Francisco, California, United States |
